TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 174 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $533,898 | +14.0% | 34,759 | +56.2% | 0.00% | +100.0% |
| Q4 2022 | $468,128 | -40.4% | 22,260 | -30.1% | 0.00% | -50.0% |
| Q3 2022 | $785,000 | +119.3% | 31,850 | +176.6% | 0.00% | +100.0% |
| Q4 2021 | $358,000 | -67.7% | 11,514 | -74.8% | 0.00% | -75.0% |
| Q3 2021 | $1,108,000 | +95.4% | 45,696 | +119.8% | 0.00% | +33.3% |
| Q4 2020 | $567,000 | – | 20,791 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MASSMUTUAL TRUST CO FSB/ADV | 235 | $2,113 | 0.00% |